Brief: Kintor Pharmaceutical Says Gt20029's Investigational New Drug Applications Approved By CDE Of NMPA
15/04/2021 15:45
April 15 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* KINTOR PHARMACEUTICAL -GT20029'S INVESTIGATIONAL NEW DRUG
APPLICATIONS FOR ANDROGENETIC ALOPECIA AND ACNE VULGARIS
APPROVED BY CDE OF NMPA
Source text for Eikon: ID:nHKS9GTKNd
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint